Overview

Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation

Status:
Recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

Summary

This is an investigator-initiated clinical trial to analysis melphalan pharmacokinetics in pediatric hematopoietic stem cell transplantation patients.

Phase:

Phase 1

Details

Lead Sponsor:

Seoul National University Hospital

Collaborator:

National Institute of Food and Drug Safety Evaluation (Republic of Korea)

Treatments:

Melphalan